Product Information
NORETHIND-ETH ESTRAD 1-0.02 MG is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1842 per EA under NDC 00378728053. Its NADAC has been published 624 times since Sep 10, 2014.
FDA first approved this application on Nov 6, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.02; 1 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378728053
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ETHINYL ESTRADIOL; NORETHINDRONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA202771FDA Approved
11/6/2013
TE Code
AB
On Market Since
7/11/2014
Price Statistics
The NADAC for NORETHIND-ETH ESTRAD 1-0.02 MG has been published 624 times since Sep 10, 2014, and over the history we have for it it has declined 73.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1842 per EA |
|---|---|
| All-time high | $0.8827 (Jan 13, 2016) |
| All-time low | $0.1619 (Nov 20, 2024) |
| 52-week high | $0.1842 |
| 52-week low | $0.1652 |
| Median price | $0.3520 |
| Average price | $0.4131 |
| Largest weekly change | +37.1% (May 22, 2019) |
| Weeks tracked | 624 |
| Tracking since | Sep 10, 2014 |
1W
N/A
1M
N/A
3M
+5.8%
6M
+10.0%
1Y
+7.0%
3Y
-18.8%
5Y
-48.5%
All
-73.6%
Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
norethindrone acetate and ethinyl estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NORETHIND-ETH ESTRAD 1-0.02 MG?
The current National Average Drug Acquisition Cost (NADAC) for NORETHIND-ETH ESTRAD 1-0.02 MG, manufactured by Mylan Pharmaceuticals Inc., is $0.1842 per EA (NDC 00378728053), effective Aug 19, 2026.
How has the price of NORETHIND-ETH ESTRAD 1-0.02 MG changed over time?
Over the history we have for it, the NADAC for NORETHIND-ETH ESTRAD 1-0.02 MG has declined 73.6%. It has been tracked across 624 weekly CMS publications since Sep 10, 2014.
What are the highest and lowest recorded NADAC prices for NORETHIND-ETH ESTRAD 1-0.02 MG?
Since Sep 10, 2014, the NADAC for NORETHIND-ETH ESTRAD 1-0.02 MG has ranged from a low of $0.1619 (Nov 20, 2024) to a high of $0.8827 (Jan 13, 2016), with a median of $0.3520 per EA.
Are there cheaper alternatives to NORETHIND-ETH ESTRAD 1-0.02 MG?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LUIZZA 1 MG-20 MCG TABLET, is $0.1812 per EA — about 2% below NORETHIND-ETH ESTRAD 1-0.02 MG.
Who manufactures NORETHIND-ETH ESTRAD 1-0.02 MG?
NORETHIND-ETH ESTRAD 1-0.02 MG (NDC 00378728053) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.